A new wave of surgical robotics companies is driving innovation in the sector.
These upstarts are tackling cost and infrastructure barriers to expand robotic surgery beyond large hospitals and academic medical centers. Some are pushing into complex specialties such as cardiac surgery and neurosurgery.
Progress is accelerating, as more companies pick up U.S. authorizations. In our latest profile, MedTech Dive spoke with MMI CEO Mark Toland about the company’s efforts in microsurgery, where the Symani robot is being used in intricate procedures such as tissue transfer and lymphatic repair.
Executives at eight companies taking the field of robotic surgery in new directions spoke with MedTech Dive about how the platforms are poised to transform patient care. Read about their progress in the profiles below.
